Campaign Donors: Phamaceutical

• During his U.S. Senate career, Lieberman provided significant assistance to the pharmaceutical industry.

• Lieberman helped pass an amendment that prevented low-priced generic drugs from being made available to consumers earlier. (HR 1833, Senate Vote 594, 12/7/95)

• Lieberman voted to table an amendment that required manufacturers of medical devices like syringes to be fully accurate in labeling. (S 830, Senate Vote 254, 9/23/97)

• Lieberman voted to make it optional, rather than mandatory, for producers of medical devices like pacemakers and artificial heart valves to track the performance of their products after implantation. (S 830, Senate Vote 253, 9/23/97)

• Lieberman voted against federally regulated price controls on prescription drugs. He voted to table an amendment that required drug makers to agree to sell patented products at a price determined by the Secretary of Health and Human Services. (HR 4577, Senate Vote 168, 6/30/00)

• Lieberman sponsored legislation that extended patent protections for drug companies that develop defenses against biological weapons. Along with Republican Senators Orrin Hatch and Sam Brownback, Lieberman was a sponsor of “BioShield” legislation, which included a “wild-card patent extension” potentially worth billions by shielding a drug company’s products from generic competition for up to 18 months. (Washington Post, 8/7/05)

• Over his career, Lieberman has accepted more than $400,000 in campaign contributions from prescription drug and medical device manufacturers. According to the Center for Responsive Politics, he has received $419,600 during his Senate career. Purdue Pharma has been his seventh-largest contributor, giving him $84,000, and Pfizer has been his 12^th largest contributor, giving him $67,900 over his career. (Center for Responsive Politics)

• Lieberman’s wife is a veteran and beneficiary of the pharmaceutical industry. Hadassah Lieberman’s past employers have included lobbying firms with pharmaceutical industry clients, as well as Pfizer and Hoffman-LaRoche. Lieberman’s wife is also a stockholder in Pfizer. (Secretary of the Senate; Senate Office of Public Records; Washington Post, 3/17/05)